Initiating Phase I/II clinical trials on patients at risk or already infected

Projects should leverage clinical trials expertise to rapidly intiate clinical trials for prevention and/or treatment for COVID-19

Amount
Not limited
Eligibility (if available)

Must already possess an NHLBI Phase I-III clinical trial award

Foreign participation? (where known)
No
Country
Date of announcement
Date application deadline